vs
AtriCure, Inc.（ATRC）与FTAI Infrastructure Inc.（FIP）财务数据对比。点击上方公司名可切换其他公司
FTAI Infrastructure Inc.的季度营收约是AtriCure, Inc.的1.3倍（$188.4M vs $141.2M），AtriCure, Inc.净利率更高（0.1% vs -79.7%，领先79.8%），FTAI Infrastructure Inc.同比增速更快（95.9% vs 14.3%），过去两年FTAI Infrastructure Inc.的营收复合增速更高（49.0% vs 10.2%）
AtriCure是一家专注于心房颤动及相关心脏病症治疗的医疗设备企业，研发并生产创新外科手术工具与疗法，主要服务北美、欧洲、亚太地区的医院、心脏外科中心及医疗机构，为微创心脏手术提供高效可靠的适配解决方案。
FTAI基础设施有限公司持有、运营并投资交通物流、中游能源、发电等核心领域的优质关键基础设施资产，主要面向北美市场，聚焦拥有稳定长期现金流、合同约定收入流的项目，为利益相关方创造可持续回报。
ATRC vs FIP — 直观对比
营收规模更大
FIP
是对方的1.3倍
$141.2M
营收增速更快
FIP
高出81.6%
14.3%
净利率更高
ATRC
高出79.8%
-79.7%
两年增速更快
FIP
近两年复合增速
10.2%
损益表 — Q1 FY2026 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $141.2M | $188.4M |
| 净利润 | $108.0K | $-150.2M |
| 毛利率 | 77.4% | — |
| 营业利润率 | 23.0% | — |
| 净利率 | 0.1% | -79.7% |
| 营收同比 | 14.3% | 95.9% |
| 净利润同比 | — | -387.6% |
| 每股收益（稀释后） | $0.00 | $-1.32 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ATRCFIP
| Q1 26 | $141.2M | $188.4M | ||
| Q4 25 | $140.5M | $143.5M | ||
| Q3 25 | $134.3M | $140.6M | ||
| Q2 25 | $136.1M | $122.3M | ||
| Q1 25 | $123.6M | $96.2M | ||
| Q4 24 | $124.3M | $80.8M | ||
| Q3 24 | $115.9M | $83.3M | ||
| Q2 24 | $116.3M | $84.9M |
净利润ATRCFIP
| Q1 26 | $108.0K | $-150.2M | ||
| Q4 25 | — | $-97.7M | ||
| Q3 25 | $-267.0K | $-104.5M | ||
| Q2 25 | $-6.2M | $-70.0M | ||
| Q1 25 | $-6.7M | $120.2M | ||
| Q4 24 | — | $-124.7M | ||
| Q3 24 | $-7.9M | $-43.0M | ||
| Q2 24 | $-8.0M | $-48.1M |
毛利率ATRCFIP
| Q1 26 | 77.4% | — | ||
| Q4 25 | 75.0% | — | ||
| Q3 25 | 75.5% | — | ||
| Q2 25 | 74.5% | — | ||
| Q1 25 | 74.9% | — | ||
| Q4 24 | 74.5% | — | ||
| Q3 24 | 74.9% | — | ||
| Q2 24 | 74.7% | — |
营业利润率ATRCFIP
| Q1 26 | 23.0% | — | ||
| Q4 25 | 1.8% | -45.7% | ||
| Q3 25 | 0.2% | -70.8% | ||
| Q2 25 | -4.5% | -56.4% | ||
| Q1 25 | -4.8% | 81.8% | ||
| Q4 24 | -11.7% | -152.7% | ||
| Q3 24 | -6.4% | -51.7% | ||
| Q2 24 | -6.2% | -56.4% |
净利率ATRCFIP
| Q1 26 | 0.1% | -79.7% | ||
| Q4 25 | — | -68.1% | ||
| Q3 25 | -0.2% | -74.4% | ||
| Q2 25 | -4.5% | -57.2% | ||
| Q1 25 | -5.5% | 125.0% | ||
| Q4 24 | — | -154.4% | ||
| Q3 24 | -6.8% | -51.6% | ||
| Q2 24 | -6.9% | -56.7% |
每股收益（稀释后）ATRCFIP
| Q1 26 | $0.00 | $-1.32 | ||
| Q4 25 | $0.04 | $-1.04 | ||
| Q3 25 | $-0.01 | $-1.38 | ||
| Q2 25 | $-0.13 | $-0.73 | ||
| Q1 25 | $-0.14 | $0.89 | ||
| Q4 24 | $-0.33 | $-1.21 | ||
| Q3 24 | $-0.17 | $-0.45 | ||
| Q2 24 | $-0.17 | $-0.52 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $146.2M | $37.9M |
| 总债务越低越好 | $61.0M | — |
| 股东权益账面价值 | $491.7M | $-122.5K |
| 总资产 | $644.0M | $5.7B |
| 负债/权益比越低杠杆越低 | 0.12× | — |
8季度趋势，按日历期对齐
现金及短期投资ATRCFIP
| Q1 26 | $146.2M | $37.9M | ||
| Q4 25 | $167.4M | $57.4M | ||
| Q3 25 | $147.9M | $34.7M | ||
| Q2 25 | $117.8M | $33.6M | ||
| Q1 25 | $99.9M | $26.3M | ||
| Q4 24 | $122.7M | $27.8M | ||
| Q3 24 | $130.3M | $20.3M | ||
| Q2 24 | $114.0M | $33.1M |
总债务ATRCFIP
| Q1 26 | $61.0M | — | ||
| Q4 25 | — | $3.8B | ||
| Q3 25 | $61.9M | $3.7B | ||
| Q2 25 | $61.9M | $3.1B | ||
| Q1 25 | $61.9M | $2.8B | ||
| Q4 24 | — | $1.6B | ||
| Q3 24 | $61.9M | $1.5B | ||
| Q2 24 | $61.9M | $1.6B |
股东权益ATRCFIP
| Q1 26 | $491.7M | $-122.5K | ||
| Q4 25 | $491.9M | $21.3M | ||
| Q3 25 | $476.5M | $181.1M | ||
| Q2 25 | $464.5M | $375.5M | ||
| Q1 25 | $454.6M | $476.2M | ||
| Q4 24 | $461.0M | $202.7M | ||
| Q3 24 | $465.0M | $370.8M | ||
| Q2 24 | $462.1M | $394.8M |
总资产ATRCFIP
| Q1 26 | $644.0M | $5.7B | ||
| Q4 25 | $654.2M | $5.7B | ||
| Q3 25 | $635.4M | $5.5B | ||
| Q2 25 | $608.8M | $4.4B | ||
| Q1 25 | $591.6M | $4.1B | ||
| Q4 24 | $609.3M | $2.4B | ||
| Q3 24 | $615.1M | $2.4B | ||
| Q2 24 | $597.3M | $2.5B |
负债/权益比ATRCFIP
| Q1 26 | 0.12× | — | ||
| Q4 25 | — | 176.99× | ||
| Q3 25 | 0.13× | 20.59× | ||
| Q2 25 | 0.13× | 8.21× | ||
| Q1 25 | 0.14× | 5.79× | ||
| Q4 24 | — | 7.84× | ||
| Q3 24 | 0.13× | 4.14× | ||
| Q2 24 | 0.13× | 3.94× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $-69.4M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流ATRCFIP
| Q1 26 | — | $-69.4M | ||
| Q4 25 | $20.0M | $-2.8M | ||
| Q3 25 | $26.7M | $-24.4M | ||
| Q2 25 | $21.6M | $-5.2M | ||
| Q1 25 | $-11.0M | $-85.7M | ||
| Q4 24 | $5.8M | $-8.1M | ||
| Q3 24 | $20.0M | $14.2M | ||
| Q2 24 | $7.4M | $-17.6M |
自由现金流ATRCFIP
| Q1 26 | — | — | ||
| Q4 25 | $18.4M | $-68.6M | ||
| Q3 25 | $24.1M | $-90.7M | ||
| Q2 25 | $19.0M | $-87.5M | ||
| Q1 25 | $-13.2M | $-151.7M | ||
| Q4 24 | $3.1M | $-34.3M | ||
| Q3 24 | $16.4M | $-11.7M | ||
| Q2 24 | $5.0M | $-32.1M |
自由现金流率ATRCFIP
| Q1 26 | — | — | ||
| Q4 25 | 13.1% | -47.8% | ||
| Q3 25 | 18.0% | -64.5% | ||
| Q2 25 | 13.9% | -71.6% | ||
| Q1 25 | -10.7% | -157.7% | ||
| Q4 24 | 2.5% | -42.4% | ||
| Q3 24 | 14.1% | -14.0% | ||
| Q2 24 | 4.3% | -37.9% |
资本支出强度ATRCFIP
| Q1 26 | — | — | ||
| Q4 25 | 1.1% | 45.9% | ||
| Q3 25 | 1.9% | 47.2% | ||
| Q2 25 | 2.0% | 67.3% | ||
| Q1 25 | 1.8% | 68.6% | ||
| Q4 24 | 2.2% | 32.5% | ||
| Q3 24 | 3.1% | 31.1% | ||
| Q2 24 | 2.1% | 17.2% |
现金转化率ATRCFIP
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | -0.71× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ATRC
| Appendage management | $48.4M | 34% |
| Open ablation | $39.1M | 28% |
| Other | $25.0M | 18% |
| Pain management | $22.4M | 16% |
| Minimally invasive ablation | $6.4M | 5% |
FIP
暂无分部数据
